弗拉维病毒非结构性蛋白1驱动通过组织因子携带的微小囊凝血:试点研究
Silvia Beltrami1, Matteo Ferraresi1, Giorgia Cianci1
1Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara 44121, Italy.
ACS omega
|December 1, 2025
概括
弗拉维病毒非结构性蛋白 sNS1 影响血液凝结和炎症不同,取决于病毒类型. 神经旋性黄状病毒sNS1促进凝血,而出血性黄状病毒sNS1抑制它,影响疾病的严重程度.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 弗拉维病毒引起了全球重要的健康问题,其临床结果各不相同.
- 分泌的非结构蛋白1 (sNS1) 涉及到弗拉维病毒的发病过程.
- sNS1在调节宿主凝血和炎症中的作用仍然不完全理解.
研究的目的:
- 调查sNS1与神经向性和出血性黄病毒对凝血和炎症的差异性影响.
- 探索sNS1介导的血管变化的潜在机制.
主要方法:
- 利用人类单细胞 (THP-1) 细胞研究sNS1-宿主相互作用.
- 评估了组织因子 (TF) 表达和TF携带的微粒细胞释放.
- 测量了炎症性细胞因子,IN-6 (IL-6) 的水平.
主要成果:
- 来自神经向性黄病毒 (例如西尼罗河病毒) 的sNS1增加了TF表达和促凝活性.
- 来自出血性黄病毒 (例如登革热病毒) 的sNS1表现出抗凝固作用.
- 不同的sNS1活动与差异性IL-6调制相关,突出显示了炎症的作用.
结论:
- 弗拉维病毒sNS1是一种关键的毒性因子,调节宿主血液静止和免疫力.
- 病毒特异性的sNS1活动有助于各种各样的黄状病毒临床表现.
- sNS1 是一种潜在的治疗点,可用于发炎病毒感染.
更多相关视频
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
14.3K
04:56Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
1.2K
相关概念视频
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
Coagulation
9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K
Coagulation
1.2K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.2K
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
